<p>Zimmer Biomet Holdings, Inc. (NYSE:ZBH - 获取免费报告) 的股价在周一的午盘交易中达到了新的 52 周低点。该股最低交易价格为 79.60 美元，最后交易价格为 79.1940 美元，成交量为 672006 股。该股此前收盘价为 82.33 美元。</p>
<p>获取 <strong>Zimmer Biomet</strong> 的提醒：</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>深入分析医疗行业收益：AZN vs. EW vs. ZBH</li>
</ul>
<p>几位研究分析师最近对该公司进行了评论。Truist Financial 在 4 月 29 日的研究报告中重申了对 Zimmer Biomet 的 “持有” 评级，并将目标价设定为 92.00 美元（从 98.00 美元下调）。摩根大通将 Zimmer Biomet 的目标价从 100.00 美元下调至 95.00 美元，并在 4 月 29 日的研究报告中对该股给予 “中性” 评级。Wall Street Zen 在周六的报告中将 Zimmer Biomet 的评级从 “持有” 上调至 “买入”。Canaccord Genuity Group 在 4 月 29 日的报告中将 Zimmer Biomet 的目标价设定为 83.00 美元。最后，Needham &amp; Company LLC 在 2 月 10 日的研究报告中重新发布了对 Zimmer Biomet 的 “持有” 评级。一位研究分析师给予该股 “强烈买入” 评级，七位分析师给予 “买入” 评级，十二位分析师给予 “持有” 评级，三位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 102.80 美元。</p>
<p><strong>查看我们最新的 ZBH 股票报告</strong></p>
<h2>Zimmer Biomet 股价下跌 3.2%</h2>
<ul>
<li>Intuitive Surgical 在机器人手术创新中领先</li>
</ul>
<p>该公司的 50 日移动平均价格为 91.56 美元，200 日移动平均价格为 92.31 美元。公司的速动比率为 0.95，流动比率为 1.73，债务与股本比率为 0.50。公司的市值为 154.1 亿美元，市盈率为 20.69，PEG 比率为 1.90，贝塔值为 0.48。</p>
<p>Zimmer Biomet (NYSE:ZBH - 获取免费报告) 最近在 4 月 28 日宣布了其财报。该医疗设备提供商报告本季度每股收益为 2.09 美元，超出分析师共识预期的 1.86 美元，超出幅度为 0.23 美元。该公司本季度的收入为 20.9 亿美元，而分析师预期为 20.7 亿美元。Zimmer Biomet 的股本回报率为 13.24%，净利润率为 9.05%。该公司的季度收入同比增长 9.3%。去年同期，该公司每股收益为 1.81 美元。Zimmer Biomet 已将其 2026 财年的指导目标设定为 8.400-8.550 每股收益。分析师平均预测 Zimmer Biomet Holdings, Inc.在当前年度将发布 8.47 每股收益。</p>
<h2>Zimmer Biomet 股息公告</h2>
<ul>
<li>2 家机器人手术股票挑战 Intuitive Surgical 的领先地位</li>
</ul>
<p>该公司最近还宣布了季度股息，该股息于 4 月 30 日支付。3 月 31 日的股东获得每股 0.24 美元的股息。该股息的除息日期为 3 月 31 日。这相当于每年 0.96 美元的股息，股息收益率为 1.2%。Zimmer Biomet 的股息支付比率（DPR）目前为 24.94%。</p>
<h2>内部交易活动</h2>
<p>在其他新闻中，SVP Lori Winkler 在 3 月 12 日的交易中出售了 2650 股该公司的股票。股票以平均价格 94.66 美元出售，总价值为 250,849.00 美元。出售完成后，该高级副总裁持有公司股票 10,224 股，价值约为 967,803.84 美元。此次交易使其持股减少了 20.58%。该出售在与 SEC 的法律文件中披露，可以通过此链接访问。内部人士持有公司股票的 1.28%。</p>
<h2>Zimmer Biomet 的机构交易</h2>
<p>几家对冲基金和其他机构投资者最近买卖了该公司的股票。M&amp;T Bank Corp 在第四季度将其在 Zimmer Biomet 的持股增加了 15,705.6%。M&amp;T Bank Corp 目前拥有 3571595 股该医疗设备提供商的股票，价值为 3.21158 亿美元，此前在该期间内又购买了 3548998 股。挪威银行在第四季度购买了 Zimmer Biomet 的新股份，价值约为 2.21234 亿美元。富兰克林资源公司在第四季度将其在 Zimmer Biomet 的持股增加了 43.2%。富兰克林资源公司目前拥有 6685987 股该医疗设备提供商的股票，价值为 6.01204 亿美元，此前在上个季度又购买了 2017857 股。Auto Owners Insurance Co 在第四季度将其在 Zimmer Biomet 的持股增加了 8892.0%。Auto Owners Insurance Co 目前拥有 2009712 股该医疗设备提供商的股票，价值为 1.80713 亿美元，此前在上个季度又购买了 1987362 股。最后，Dodge &amp; Cox 在第三季度将其在 Zimmer Biomet 的持股增加了 5.1%。Dodge &amp; Cox 目前拥有 23216173 股该医疗设备提供商的股票，价值为 22.86793 亿美元，此前在该期间内又收购了 1118710 股。机构投资者和对冲基金持有公司 88.89% 的股票。</p>
<h2>关于 Zimmer Biomet</h2>
<p>(获取免费报告)</p>
<p>Zimmer Biomet NYSE: ZBH 是一家全球医疗设备公司，专注于肌肉骨骼健康护理。公司总部位于印第安纳州华沙，设计、制造和销售广泛的产品组合，用于治疗关节疾病、骨骼疾病及相关病症。其客户包括依赖于植入物、仪器和相关服务进行重建和修复程序的骨科和牙科外科医生、医院、门诊手术中心及其他医疗服务提供者。</p>
<p>该公司的产品涵盖髋关节、膝关节和肩关节的关节置换系统；创伤和四肢植入物；脊柱和胸部解决方案；牙科和颅面植入物及假体；以及运动医学设备。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票超过 Zimmer Biomet</li>
<li>在月球基地建成之前，这四家公司获胜</li>
<li>工业回购：顶级住宅建筑供应商引领回购增加</li>
<li>如果通胀意外下行，这三只股票将受益</li>
<li>MercadoLibre 大胆投资于增长：折扣加深</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Zimmer Biomet 吗？</h2>
<p>在考虑 Zimmer Biomet 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Zimmer Biomet 并不在名单上。</p>
<p>虽然 Zimmer Biomet 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Zimmer Biomet（纽约证券交易所代码：ZBH）创下 52 周新低，报 79.60 美元，收盘价为 79.1940 美元，交易量为 672,006 股。分析师的评级意见不一，普遍维持持有评级，目标价为 102.80 美元。该公司每股收益为 2.09 美元，超出预期，营收为 20.9 亿美元，同比增长 9.3%。最近支付的季度股息为 0.24 美元，收益率为 1.2%。内部交易活动包括高级副总裁 Lori Winkler 的出售，机构投资者显著增加了持股</p>

<p>Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Get Free Report)'s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $79.60 and last traded at $79.1940, with a volume of 672006 shares trading hands. The stock had previously closed at $82.33.</p>
<div class="lb-trans"><p>Zimmer Biomet Holdings, Inc. (NYSE:ZBH - 获取免费报告) 的股价在周一的午盘交易中达到了新的 52 周低点。该股最低交易价格为 79.60 美元，最后交易价格为 79.1940 美元，成交量为 672006 股。该股此前收盘价为 82.33 美元。</p>
</div><p>Get <strong>Zimmer Biomet</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Zimmer Biomet</strong> 的提醒：</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH</li>
</ul>
<div class="lb-trans"><ul>
<li>深入分析医疗行业收益：AZN vs. EW vs. ZBH</li>
</ul>
</div><p>Several research analysts have recently commented on the company. Truist Financial reiterated a &#34;hold&#34; rating and set a $92.00 target price (down from $98.00) on shares of Zimmer Biomet in a research note on Wednesday, April 29th. JPMorgan Chase &amp; Co. dropped their price target on Zimmer Biomet from $100.00 to $95.00 and set a &#34;neutral&#34; rating on the stock in a research note on Wednesday, April 29th. Wall Street Zen raised Zimmer Biomet from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday. Canaccord Genuity Group set a $83.00 price objective on shares of Zimmer Biomet in a report on Wednesday, April 29th. Finally, Needham &amp; Company LLC reissued a &#34;hold&#34; rating on shares of Zimmer Biomet in a research report on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, twelve have issued a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of &#34;Hold&#34; and a consensus price target of $102.80.</p>
<div class="lb-trans"><p>几位研究分析师最近对该公司进行了评论。Truist Financial 在 4 月 29 日的研究报告中重申了对 Zimmer Biomet 的 “持有” 评级，并将目标价设定为 92.00 美元（从 98.00 美元下调）。摩根大通将 Zimmer Biomet 的目标价从 100.00 美元下调至 95.00 美元，并在 4 月 29 日的研究报告中对该股给予 “中性” 评级。Wall Street Zen 在周六的报告中将 Zimmer Biomet 的评级从 “持有” 上调至 “买入”。Canaccord Genuity Group 在 4 月 29 日的报告中将 Zimmer Biomet 的目标价设定为 83.00 美元。最后，Needham &amp; Company LLC 在 2 月 10 日的研究报告中重新发布了对 Zimmer Biomet 的 “持有” 评级。一位研究分析师给予该股 “强烈买入” 评级，七位分析师给予 “买入” 评级，十二位分析师给予 “持有” 评级，三位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 102.80 美元。</p>
</div><p><strong>View Our Latest Stock Report on ZBH</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 ZBH 股票报告</strong></p>
</div><h2>Zimmer Biomet Trading Down 3.2%</h2>
<div class="lb-trans"><h2>Zimmer Biomet 股价下跌 3.2%</h2>
</div><ul>
<li>Intuitive Surgical Leads the Pack in Robotic Surgery Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 在机器人手术创新中领先</li>
</ul>
</div><p>The business has a fifty day moving average price of $91.56 and a 200-day moving average price of $92.31. The company has a quick ratio of 0.95, a current ratio of 1.73 and a debt-to-equity ratio of 0.50. The company has a market cap of $15.41 billion, a P/E ratio of 20.69, a PEG ratio of 1.90 and a beta of 0.48.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 91.56 美元，200 日移动平均价格为 92.31 美元。公司的速动比率为 0.95，流动比率为 1.73，债务与股本比率为 0.50。公司的市值为 154.1 亿美元，市盈率为 20.69，PEG 比率为 1.90，贝塔值为 0.48。</p>
</div><p>Zimmer Biomet (NYSE:ZBH - Get Free Report) last announced its earnings results on Tuesday, April 28th. The medical equipment provider reported $2.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.86 by $0.23. The company had revenue of $2.09 billion for the quarter, compared to analyst estimates of $2.07 billion. Zimmer Biomet had a return on equity of 13.24% and a net margin of 9.05%.The firm's quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.81 earnings per share. Zimmer Biomet has set its FY 2026 guidance at 8.400-8.550 EPS. On average, analysts forecast that Zimmer Biomet Holdings, Inc. will post 8.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>Zimmer Biomet (NYSE:ZBH - 获取免费报告) 最近在 4 月 28 日宣布了其财报。该医疗设备提供商报告本季度每股收益为 2.09 美元，超出分析师共识预期的 1.86 美元，超出幅度为 0.23 美元。该公司本季度的收入为 20.9 亿美元，而分析师预期为 20.7 亿美元。Zimmer Biomet 的股本回报率为 13.24%，净利润率为 9.05%。该公司的季度收入同比增长 9.3%。去年同期，该公司每股收益为 1.81 美元。Zimmer Biomet 已将其 2026 财年的指导目标设定为 8.400-8.550 每股收益。分析师平均预测 Zimmer Biomet Holdings, Inc.在当前年度将发布 8.47 每股收益。</p>
</div><h2>Zimmer Biomet Dividend Announcement</h2>
<div class="lb-trans"><h2>Zimmer Biomet 股息公告</h2>
</div><ul>
<li>2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead</li>
</ul>
<div class="lb-trans"><ul>
<li>2 家机器人手术股票挑战 Intuitive Surgical 的领先地位</li>
</ul>
</div><p>The company also recently announced a quarterly dividend, which was paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st were issued a dividend of $0.24 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.2%. Zimmer Biomet's dividend payout ratio (DPR) is currently 24.94%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度股息，该股息于 4 月 30 日支付。3 月 31 日的股东获得每股 0.24 美元的股息。该股息的除息日期为 3 月 31 日。这相当于每年 0.96 美元的股息，股息收益率为 1.2%。Zimmer Biomet 的股息支付比率（DPR）目前为 24.94%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In other news, SVP Lori Winkler sold 2,650 shares of the business's stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $94.66, for a total value of $250,849.00. Following the completion of the sale, the senior vice president owned 10,224 shares of the company's stock, valued at approximately $967,803.84. The trade was a 20.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.28% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，SVP Lori Winkler 在 3 月 12 日的交易中出售了 2650 股该公司的股票。股票以平均价格 94.66 美元出售，总价值为 250,849.00 美元。出售完成后，该高级副总裁持有公司股票 10,224 股，价值约为 967,803.84 美元。此次交易使其持股减少了 20.58%。该出售在与 SEC 的法律文件中披露，可以通过此链接访问。内部人士持有公司股票的 1.28%。</p>
</div><h2>Institutional Trading of Zimmer Biomet</h2>
<div class="lb-trans"><h2>Zimmer Biomet 的机构交易</h2>
</div><p>Several hedge funds and other institutional investors have recently bought and sold shares of the business. M&amp;T Bank Corp increased its holdings in shares of Zimmer Biomet by 15,705.6% during the fourth quarter. M&amp;T Bank Corp now owns 3,571,595 shares of the medical equipment provider's stock worth $321,158,000 after purchasing an additional 3,548,998 shares during the period. Norges Bank bought a new stake in shares of Zimmer Biomet in the fourth quarter valued at approximately $221,234,000. Franklin Resources Inc. grew its position in Zimmer Biomet by 43.2% during the fourth quarter. Franklin Resources Inc. now owns 6,685,987 shares of the medical equipment provider's stock worth $601,204,000 after buying an additional 2,017,857 shares in the last quarter. Auto Owners Insurance Co grew its position in Zimmer Biomet by 8,892.0% during the fourth quarter. Auto Owners Insurance Co now owns 2,009,712 shares of the medical equipment provider's stock worth $180,713,000 after buying an additional 1,987,362 shares in the last quarter. Finally, Dodge &amp; Cox increased its stake in Zimmer Biomet by 5.1% during the 3rd quarter. Dodge &amp; Cox now owns 23,216,173 shares of the medical equipment provider's stock worth $2,286,793,000 after acquiring an additional 1,118,710 shares during the period. Institutional investors and hedge funds own 88.89% of the company's stock.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近买卖了该公司的股票。M&amp;T Bank Corp 在第四季度将其在 Zimmer Biomet 的持股增加了 15,705.6%。M&amp;T Bank Corp 目前拥有 3571595 股该医疗设备提供商的股票，价值为 3.21158 亿美元，此前在该期间内又购买了 3548998 股。挪威银行在第四季度购买了 Zimmer Biomet 的新股份，价值约为 2.21234 亿美元。富兰克林资源公司在第四季度将其在 Zimmer Biomet 的持股增加了 43.2%。富兰克林资源公司目前拥有 6685987 股该医疗设备提供商的股票，价值为 6.01204 亿美元，此前在上个季度又购买了 2017857 股。Auto Owners Insurance Co 在第四季度将其在 Zimmer Biomet 的持股增加了 8892.0%。Auto Owners Insurance Co 目前拥有 2009712 股该医疗设备提供商的股票，价值为 1.80713 亿美元，此前在上个季度又购买了 1987362 股。最后，Dodge &amp; Cox 在第三季度将其在 Zimmer Biomet 的持股增加了 5.1%。Dodge &amp; Cox 目前拥有 23216173 股该医疗设备提供商的股票，价值为 22.86793 亿美元，此前在该期间内又收购了 1118710 股。机构投资者和对冲基金持有公司 88.89% 的股票。</p>
</div><h2>About Zimmer Biomet</h2>
<div class="lb-trans"><h2>关于 Zimmer Biomet</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Zimmer Biomet NYSE: ZBH is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.</p>
<div class="lb-trans"><p>Zimmer Biomet NYSE: ZBH 是一家全球医疗设备公司，专注于肌肉骨骼健康护理。公司总部位于印第安纳州华沙，设计、制造和销售广泛的产品组合，用于治疗关节疾病、骨骼疾病及相关病症。其客户包括依赖于植入物、仪器和相关服务进行重建和修复程序的骨科和牙科外科医生、医院、门诊手术中心及其他医疗服务提供者。</p>
</div><p>The company's product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.</p>
<div class="lb-trans"><p>该公司的产品涵盖髋关节、膝关节和肩关节的关节置换系统；创伤和四肢植入物；脊柱和胸部解决方案；牙科和颅面植入物及假体；以及运动医学设备。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Zimmer Biomet</li>
<li>Before the Moon Base Gets Built, These 4 Companies Win</li>
<li>Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases</li>
<li>3 Stocks That Win If Inflation Surprises to the Downside</li>
<li>MercadoLibre Boldly Invests in Growth: Discount Deepens</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Zimmer Biomet</li>
<li>在月球基地建成之前，这四家公司获胜</li>
<li>工业回购：顶级住宅建筑供应商引领回购增加</li>
<li>如果通胀意外下行，这三只股票将受益</li>
<li>MercadoLibre 大胆投资于增长：折扣加深</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Zimmer Biomet Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Zimmer Biomet 吗？</h2>
</div><p>Before you consider Zimmer Biomet, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Zimmer Biomet 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zimmer Biomet wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Zimmer Biomet 并不在名单上。</p>
</div><p>While Zimmer Biomet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Zimmer Biomet 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Zimmer Biomet（NYSE:ZBH）创下 12 个月新低 - 以下是原因